Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share Latest Annual | GKSL FY26 | GPTHEALTH FY26 | SHALBY FY26 | INDRAMEDCO FY26 | Peer Average | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 69.02× | 26.58× | 37.76× | ◆ 15.89× | 26.74× +158% | |
| P/B | 5.37× | 4.17× | ◆ 1.30× | 3.94× | 3.14× +71% | |
| EV/EBITDA | 48.88× | 12.97× | 12.38× | ◆ 9.95× | 11.77× +315% | |
| Market Cap | ₹1,355 Cr | ₹1,123 Cr | ₹1,311 Cr | ₹2,918 Cr | ₹1,784 Cr -24% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | — | ◆ 12.35% | 10.50% | 11.43% | |
| Revenue CAGR 5Y | — | — | — | 19.30% | 19.30% | |
| Net Income CAGR 3Y | — | — | -19.97% | ◆ 28.69% | 4.36% | |
| Revenue YoY (latest Q) | — | ◆ 17.83% | 11.74% | 8.35% | 12.64% | |
| Net Income YoY (latest Q) | — | ◆ 65.73% | 36.70% | 8.33% | 36.92% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 32.85% | 17.81% | 12.51% | 18.00% | 16.11% +104% | |
| Net Income Margin | ◆ 20.50% | 8.93% | 3.04% | 12.39% | 8.12% +152% | |
| Return on Common Equity | 6.14% | 16.32% | 3.74% | ◆ 27.47% | 15.84% -61% | |
| Return on Capital Employed | 8.24% | 16.42% | 5.79% | ◆ 29.88% | 17.36% -53% | |
| Return on Assets | 5.65% | 9.95% | 1.96% | ◆ 19.93% | 10.61% -47% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.06× | 0.06× | 0.54× | ◆ 0.00× | 0.20× -70% | |
| Interest Coverage | 11.84× | 6.93× | 1.87× | ◆ 37.09× | 15.30× -23% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹82 Cr | ₹473 Cr | ₹1,141 Cr | ₹1,483 Cr | ₹1,032 Cr -92% | |
| Net Income | ₹16.8 Cr | ₹42.2 Cr | ₹34.7 Cr | ₹184 Cr | ₹86.8 Cr -81% | |
| Total Assets | ₹298 Cr | ₹465 Cr | ₹1,839 Cr | ₹991 Cr | ₹1,098 Cr -73% | |
| EPS | ₹2.49 | ₹5.15 | ₹3.23 | ₹20.03 | ₹9.47 -74% | |
| Book Value per Share | ₹32.03 | ₹32.84 | ₹93.49 | ₹80.76 | ₹69.03 -54% | |